Grafa

Pfizer BioNTech gets Canada vaccine authorization

Health Canada authorized Pfizer and BioNTech’s Omicron XFG-adapted COVID-19 vaccine, with availability expected through Canadian ...
BioSpace

Health Canada Authorizes Pfizer and BioNTech’s Omicron XFG-Adapted COVID-19 Vaccine

COVID-19 vaccine formula targets the XFG variant, in line withPublic Health recommendations to more closely match contemporary circulating variants; The vaccine will be ...

Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine

COVID-19 vaccine formula targets the XFG variant, in line with FDA guidance to more closely match contemporary circulating ...

BioNTech Tumbles 8% as Colorectal Cancer Vaccine Trial Fails, Moderna Drops 6%, Pfizer Holds Flat

BioNTech's colorectal cancer vaccine just collapsed in a Phase 2 trial, dragging Moderna down with it despite last week's melanoma triumph, and the fallout is forcing investors to rethink how far mRNA ...
Amazon S3 on MSN

How Pfizer and BioNTech made history with their vaccine

Wondering how Pfizer and partner BioNTech developed a COVID-19 vaccine in record time without compromising safety? Dr Bill ...
Seeking Alpha

Pfizer is said to divest remaining stake in BioNTech

BioNTech (BNTX) ADRs lost ~5% in the premarket on Thursday after Bloomberg News reported that Pfizer (PFE) is planning to sell its remaining stake in its partner, which helped the U.S. pharma giant to ...
Nasdaq

Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains1 Shipping of the LP.8.1-adapted vaccine will ...
Finanznachrichten

BioNTech SE: European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

Data indicate that the 2026-2027 COVID-19 vaccine formula, targeting the XFG variant, induces a strong immune response against contemporary circulating and emerging lineages More than five billion ...
Nasdaq

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages – including the XFG and NB.1.8.1 variants1 – compared to ...

Pfizer, BioNTech Secure Health Canada Authorization for Omicron XFG-Adapted COVID-19 Vaccine

Canadian operation Pfizer Canada ULC and BioNTech (BNTX) said Thursday that Health Canada has authorized XFG-adapted COMIRNATY COVID-19 vaccine for individuals aged 6 months and older. The updated ...